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The purpose of the present study was to evaluate the effect of a single intrap-
eritoneal injection of a stable analogue of endogenous cannabinoid ananda-
mide — R-(+)-methanandamide (2.5 mg/kg) and CP 55,940 (0.25 mg/kg), an
egzogenous CB1 receptor-agonist, on the calcitonin (CT) immunoreactivity of
the thyroid parafollicular (C) cells. Four hours after injection with both cannab-
inoids CT immunoreactivity, evaluated with an avidin-biotin peroxidase com-
plex method by means of rabbit antibodies against CT, was seen to be en-
hanced in the parafollicular cells in comparison to those of the control group.
In thyroids taken from cannabinoid-treated rats the majority of follicles, partic-
ularly those located peripherally were large in size, and had low epithelium.
Moreover, dilatation of the blood vessels was observed. These changes were
accompanied by a significant decrease in CT plasma level, without changes in
calcium concentrations. This is the first evidence that a single injection of the
cannabinoids R-(+)-methanandamide and CP 55,940 significantly decreases
the activity of thyroid C cells.
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INTRODUCTION
In 1970 Lomax [4] reported the inhibitory effect
of marijuana on thyroid function and indicated the
hypothalamus as the putative site of its action. Fur-
ther studies performed with D9THC, the principal psy-
choactive constituent of marijuana, [2, 5] and WIN
55,212-2 [7], a selective CB1 receptor agonist, show-
ing diminution of T3 and T4 plasma levels after a sin-
gle injection of these compounds, confirmed the
above observation. The discovery of cannabinoid
receptors and the identification of their natural
ligands, have contributed to the advancement of
cannabinoid neurobiology and pharmacology. Mam-
malian tissues contain two types of cannabinoid re-
ceptors, CB1 and CB2, both of which have been
cloned [6]. CB1 receptors are predominantly present
in the central nervous system and also in certain
peripheral tissues [6]. The high levels of CB1 mRNA
during the late embryological stages of the rat thy-
roid [1], and the recently demonstrated presence of
cannabinoid CB1 mRNA and protein in the adult rat
thyroid, both in the follicular and parafollicular (C)
cells [7], may point to the involvement of cannabinoid
receptors in mediation of thyroid gland activity. Al-
though, the levels of CB1 mRNA in the thyroid gland
were much lower than those in the brain areas, the
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presence of FAAH mRNA in the thyroid supports the
existence of an endocannabinoid system in this gland
[7].
The purpose of the present study was the evalu-
ation of a single intraperitoneal injection of a stable
analogue of endogenous cannabinoid anandamide
— R-(+)-methanandamide (2.5 mg/kg) and CP
55,940 (0.25 mg/kg), an egzogenous CB1 receptor-
agonist, on calcitonin (CT) plasma level and the CT
immunoreactivity of the thyroid parafollicular cells.
MATERIAL AND METHODS
Male Wistar rats weighing 180–185 g were used
following 7 days of acclimatisation to the laborato-
ry conditions. The animals were housed in plastic
cages, 4 animals per cage, in a temperature-con-
trolled room (20o C) and constant humidity, with
a 12/12 light/dark cycle. Food and water were freely
accessible. All procedures were performed in com-
pliance with the European Communities Council Di-
rective of 24 November 1986 (86/609/EEC) and were
approved by the Local Ethics Committee in Białystok.
R-(+)-methanandamide (Tocris) and CP 55,940
(Tocris), dissolved in a 19% solution of 2-hydroxypro-
pyl-B-cyclodextrin (RBI) were injected once, at the
intraperitoneal dose of 2.5 mg/kg and 0.25 mg/kg,
respectively. The control rats were injected with the
vehicle solution only. Each group consisted of 10
animals. Four hours after the cannabinoid injection,
under pentobarbital sodium anaesthesia (50 mg/kg),
the blood was taken from the abdominal aorta of
each rat to determine plasma CT concentration by
RIA. The rats were subsequently thyreoidectomised.
Both thyroid lobes were placed in Bouin’s fluid for
24 hours. An immunohistochemical reaction used
for detecting calcitonin in C cells was conducted on
5 µm-thick paraffin sections of the thyroid glands.
In this procedure specific rabbit antisera against CT,
which can be found only in C cells, were used. In the
above immunohistochemical study the ABC (avidin-
biotin peroxidase complex) method according to Hsu
et al. [3] was applied.
Statistical analysis: statistical comparison for
2 means were made by a Student’s t-test.
RESULTS AND DISCUSSION
Four hours after a single intraperitoneal injection
of both cannabinoids, a stable analogue of endoge-
nous cannabinoid, anandamide — R-(+)-methanan-
damide and CP 55,940, an egzogenous CB1 recep-
tor-agonist, an enhancement of CT immunoreactiv-
ity was observed in a majority of thyroid parafollicu-
lar cells (Fig. 1) in comparison to the control group
(Fig. 2). Moreover, in thyroids taken from cannab-
inoid-treated rats the majority of follicles, particu-
Figure 2. Light micrograph of the thyroid gland of a control rat.
A differentiated intensity of immunohistochemical reaction for
calcitonin in C cells is observed; × 300.
Figure 1. Light micrograph of the thyroid gland of a rat 4 hours
after a single ip. injection of CP 55,940. The micrograph presents
a piece of the gland with concentrations of C cells showing
a strong immunohistochemical reaction for calcitonin; × 300.
421
Maria M. Winnicka et al., An immunohistochemical study of the thyroid parafollicular (C) cells
larly those located peripherally, were large in size
and had low epithelium and the blood vessels were
dilated. This picture is in agreement with an obser-
vation made by Hillard et al. [2] presenting signifi-
cant reductions in TSH, T3 and T4 serum levels after
a single injection of D9THC, the principal psychoac-
tive constituent of marijuana. The significant reduc-
tions in TSH serum levels were seen at 0.25, 0.5, 1.0
and 3.0 hours, with the maximal decrease occurring
1 hour after D9THC administration, while a signifi-
cant diminution in T3 and T4 serum concentrations
was observed at 3 and 6 hours, respectively. Nazar
et al. [5] have also demonstrated a significant atten-
uation of thyroxine plasma concentration 6 hours
after a single D9THC administration or after repeat-
ing the administration over three days. The enhance-
ment of CT immunoreactivity in the parafollicular
cells, accompanied by significant diminution of CT
plasma concentration (Fig. 3), observed after a sin-
gle injection of both cannabinoids, indicates that they
also inhibit the secretion activity of C cells. This find-
ing is consistent with the recent study performed by
Porcella et al. [7] demonstrating the presence of an
endocannabinoid system in the thyroid gland, which
is probably tonically activated by endogenous can-
nabinoids, as in the central nervous system [8, 9].
Therefore, the activation of CB1 receptors, transduc-
ing signals through a pertussis toxin-sensitive Gi/Go
inhibitory pathway, located on parafollicular cells [7]
by R-(+)-methanandamide and CP 55,940, proba-
bly leads to the inhibition of calcium dependent CT
release, followed by a diminution in CT plasma con-
centration.
This is the first evidence that a single injection of
the cannabinoids R-(+)-methanandamide and CP
55,940 significantly decreases the activity of the thy-
roid parafollicular (C) cells.
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Figure 3. Effect of a single ip. injection of R-(+)-methananda-
mide (2.5 mg/kg) and CP 55,940 (0.25 mg/kg) on plasma calcito-
nin (CT) concentration. The columns represent means ± SEM of
the values obtained from 10 rats; *p < 0.05 vs. those of a con-
trol group of rats, injected with a vehicle (Student’s t test).
